Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Aryl-imidazolines and aryl-imidazoles useful as .alpha.-2 adrenergic agonists without cardiovascular side effects

Aryl-imidazolines and aryl-imidazoles useful as .alpha.-2 adrenergic agonists without cardiovascular side effects

US Patent 6087361 · Granted Jul 11, 2000

Estimated economic value: $47,094,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sodium chlorite compositions with enhanced antimicrobial efficacy and reduced to2023
Sodium chlorite compositions with enhanced anti-microbial efficacy and reduced t2021
Biodegradable drug delivery systems for the sustained release of proteins2020
Method for treating atrophic age related macular degeneration2019
Intracameral sustained release therapeutic agent implants2019
Sustained release intraocular implants and methods for treating ocular vasculopa2019
Synthesis of boronic ester and acid compounds2018
Synthesis of boronic ester and acid compounds2018
Compositions and methods for localized therapy of the eye2017
Intracameral sustained release therapeutic agent implants2016
Sustained release intraocular implants and methods for treating ocular vasculopa2015
Sustained release intraocular implants and methods for preventing retinal dysfun2015